Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (52) Blankenstein, Thomas Prof. Dr. (34) Clauß, Julian (1) Daniel, Peter Prof. Dr. (1) Fischer, Cornelius Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kammertöns, Thomas Dr. (5) Lee, Young-Ae Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Marenholz, Ingo Dr. (1) Na, Il-Kang Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Rehm, Armin Dr. (1) Uckert, Wolfgang Prof. Dr. (4) (-) Bunse, Mario Dr. (2) (-) Conrad, Thomas Dr. (1) (-) Kopp, Joachim Dr. (1) (-) Willimsky, Gerald Dr. (11) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (3) Genetik metabolischer und reproduktiver Störungen (5) (-) Genomics (1) Immunregulation und Krebs (2) Magnetic Resonance (3) Mobile DNA (1) (-) Molekulare Immunologie und Gentherapie (13) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) Zelluläre Neurowissenschaften (2) (-) 1997 (1) 1998 (1) 2000 (3) (-) 2002 (1) 2005 (4) (-) 2007 (2) 2008 (2) 2010 (4) 2011 (1) (-) 2013 (5) 2015 (2) 2016 (1) 2017 (1) (-) 2018 (5) 2019 (3) 2020 (3) 2021 (1) 2022 (8) 2023 (8) 2024 (3) 14 Ergebnisse: Active Filter: Bunse, Mario Dr.Conrad, Thomas Dr.Kopp, Joachim Dr.Willimsky, Gerald Dr.GenomicsMolekulare Immunologie und Gentherapie 19972002200720132018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder 01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel Mai 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein
Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
Mai 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse